Skip to main content
. 2014 Dec 10;15(12):22902–22917. doi: 10.3390/ijms151222902

Table 1.

Associations between clinicopathological variables and overall survival.

Variable Patients, n = 944 MST (Months) Log-Rank p HR (95% CI) d
Age (years)
≤60 442 88 0.239 1.000
>60 502 59 1.118 (0.927–1.349)
Sex
Male 727 70 0.536 1.000
Female 217 63 1.071 (0.860–1.335)
Tumor Size
≤5 cm 581 98 <0.001 1.000
>5 cm 363 48 1.422 (1.178–1.716)
Location
Non-Cardia 626 78 0.253 1.000
Cardia 318 63 0.891 (0.730–1.088)
Histological Types a
Intestinal 370 74 0.436 1.000
Diffuse 497 60 1.069 (0.918–1.244)
Differentiation a
Well to Moderate 305 80 0.518 1.000
Poorly 493 59 1.165 (0.942–1.443)
Mucinous/Signet-Ring Cell 69 62 1.199 (0.825–1.742)
Lauren a
1 399 76 <0.001 1.000
2 541 50 1.467 (1.211–1.776)
Depth of Invasion b
T1 182 84 <0.001 1.000
T2 138 78 0.540 (0.408–0.714)
T3 8 70 0.800 (0.608–1.054)
T4 594 51 1.008 (0.416–2.442)
Lymph Node Metastasis c
N0 378 81 <0.001 1.000
N1/N2/N3 566 43 1.814 (1.480–2.222)
Distant Metastasis
M0 886 74 0.004 1.000
M1 58 26 1.646 (1.165–2.326)
TNM Stage
I 250 83 <0.001 1.000
II 203 88 1.231 (0.909–1.666)
III 458 41 1.949 (1.524–2.492)
IV 25 44 2.046 (1.163–3.600)
Chemotherapy
No 638 61 0.684 1.000
Yes 306 69 1.043 (0.852–1.276)

Mean survival time was presented when the median survival time could not be measured. TNM, Tumor, Node and Metastasis; MST, median survival time; HR, hazard ratio; CI, confidence interval; AJCC, American Joint Commission on Cancer. a: Partial data were not available, and statistics were based on available data; b: Invaded depth of tumor was classified according to the criteria of AJCC 7th; c: Lymph nodes were staged according to tumor node metastasis classification of the 7th edition of AJCC in which the number of lymph nodes with a metastasis of 1–2, 3–6, and ≥7 were classified as N1, N2, and N3, respectively; d: Adjusted by age and sex.